Enzymedica has long supported autism awareness.   Enzymedica’s visionary founder, Tom Bohager, recognized the power of education and hope for families facing the autism diagnosis.  His mission was fostered through Enzymedica’s financial support of the nationwide Autism Grass Roots Tour. Bohager’s vision was later fulfilled through the creation of the Autism Hope Alliance foundation.

A key partner of the Autism Hope Alliance is the Autism Treatment Center of America™ (ATCA).  The ATCA offers five day workshops to teach parents coping skills and helpful techniques for dealing with their autistic children.  The educational home of the prestigious Son-Rise Program®, the Center has for the last thirty years helped families worldwide enable their children with autism to far outstrip their original prognoses, leading in some cases to full recovery.

Recently, Tom Bohager, Enzymedica’s founder and Operating Chairman, CEO Scott Sensenbrenner and Dave Barton Enzymedica’s Director of Education were invited to visit the Center in Sheffield, Massachusetts.  Over the course of a weekend they were given opportunity to sit in on group sessions and lectures that inspired hope and a sense of community among family members of autistic children.

Dave Barton

“The visit was a deeply moving experience,” shares Dave Barton, “but what really struck me was the enthusiasm presented by the instructors at the facility.”

Barton detailed his observation of an instructor working one-on-one with an eight year old who had no verbal or visual contact.   “The whole week for this particular boy focused on getting him to make eye contact with the teacher.  By the end of the week, the boy was not only making eye contact, but laughing as well!”

According to Dave, this experience embodies the intent of the Autism Treatment Center of America. A novel approach, the Center’s workshops enable parents to join their autistic children in their own world, rather than asking the child to enter the world of their parents.  The program places parents as key teachers, therapists and directors of their own programs, and utilizes the home as the most nurturing environment in which to help their children.

Home: Enzymedica Blog

Enzymedica, Inc., a manufacturer of enzyme focused supplements is excited to announce the appointment of Scott Sensenbrenner to the position of Chief Executive Officer.

Sensenbrenner is an accomplished leader, with a track record of working with some of the industry’s leading nutritional companies. He brings a great mix of leadership, inspiration, operational experience and a passion for customer care. His background includes working for Enzymatic Therapy where he was instrumental in helping them build the markets for several leading products such as GS500, IP-6, Esberitox, St. John’s Wort, and Remifemin.

In 2001, Sensenbrenner joined Perrigo as Group Director of their Nutrition Division, one of the largest OTC/nutritional organizations in the world with over $2 Billion in sales. Most recently, Sensenbrenner served as Vice President of Marketing & Sales for Thorne Research a leading manufacturer and marketer of therapeutic supplements sold exclusively to health care practitioners.

As Chief Executive Officer, Sensenbrenner’s responsibility will be to build upon Enzymedica’s solid foundation of leading the industry with innovative enzyme based dietary supplements.

Tom Bohager, Enzymedica’s Founder and Operating Chairman will remain active in key decisions, sharing jointly with Sensenbrenner in the development of short and long range strategies for the company.

To learn more about Enzymedica, visit the company website.

Link to us at:  Enzymedica – http://www.enzymedica.com/blog

Home: Enzymedica Blog